Glaukos (GKOS) Income from Continuing Operations (2014 - 2026)
Glaukos' (GKOS) quarterly Income from Continuing Operations came in at 19799000.0 in Q1 2026, down 9.11% year-on-year from 21783341.66 in Q1 2025, and up 85.76% on a QoQ basis from 139008000.0 in Q4 2025.
Glaukos (GKOS) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Income from Continuing Operations data on file, last reported at 19799000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 9.11% year-over-year to 19799000.0 in Q1 2026; TTM through Mar 2026 was 194695000.0, a 57.46% decrease from a year earlier, with the FY2025 full-year figure at 193042000.0, down 31.88% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 19799000.0, up from 139008000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for GKOS reached as high as 5403000.0 in Q1 2022 and fell as low as 139008000.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 35048823.53 across 5 years, with a median of 32812000.0 in 2023.
- Across the five-year window, Income from Continuing Operations soared 132.81% in 2022 and slumped 740.87% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 34347000.0 in 2022, then decreased by 7.0% to 36752000.0 in 2023, then grew by 8.63% to 33580000.0 in 2024, then sank by 313.96% to 139008000.0 in 2025, then surged by 85.76% to 19799000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 19799000.0 in Q1 2026, 139008000.0 in Q4 2025, and 16231000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | -19.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.80 Mn |
| Dec 31, 2025 | -139.01 Mn |
| Sep 30, 2025 | -16.23 Mn |
| Jun 30, 2025 | -19.66 Mn |
| Mar 31, 2025 | -18.15 Mn |
| Dec 31, 2024 | -33.58 Mn |
| Sep 30, 2024 | -21.41 Mn |
| Jun 30, 2024 | -50.51 Mn |
| Mar 31, 2024 | -40.84 Mn |
| Dec 31, 2023 | -36.75 Mn |
| Sep 30, 2023 | -30.44 Mn |
| Jun 30, 2023 | -32.81 Mn |
| Mar 31, 2023 | -34.63 Mn |
| Dec 31, 2022 | -34.35 Mn |
| Sep 30, 2022 | -27.53 Mn |
| Jun 30, 2022 | -45.54 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | -21.87 Mn |
| Sep 30, 2021 | 6.23 Mn |
| Jun 30, 2021 | -17.48 Mn |